As of 2023, malignant neoplasms mortality in Brazil stood at approximately 123.0 thousand male deaths. Forecasts indicate a steady increase from 2024 to 2028, growing from 124.07 to 128.47 thousand male deaths. Year-on-year, mortality is expected to rise by roughly 0.9% annually. The five-year compound annual growth rate (CAGR) forecasts a consistent average annual growth of about 1% from 2024 to 2028.
Future trends to watch for include advancements in cancer treatment technologies, changes in healthcare policies, and public health initiatives focusing on early detection and prevention, which could impact mortality rates. Additionally, demographic shifts such as aging population dynamics might also influence future trends.
